Project Partners

Project Partners

Prof. Dr. Niels Grabe

tl_files/tigacenter/images/eu-digipath/grabe.jpgProf. Dr. Niels Grabe is scientific director of the Hamamatsu TIGA Center at systems biological center BIOQUANT of the University Heidelberg. He was one of the earliest groups in introducing whole slide scanning into the clinic for research. As scientific group leader in the Medical Oncology Division of the National Center for Tumor Diseases (NCT) he workson novel immunotherapies. He also heads the digital pathology platform at the Institute of Pathology Heidelberg, tl_files/tigacenter/images/eu-digipath/nct.jpg organizes the leading European conference on Digital Pathology and is co(author) of over 70 papers.

 

Prof. Dr. Jenny Chang-Claude

tl_files/tigacenter/images/eu-digipath/chang-claude.jpgProf. Dr. Jenny Chang-Claude heads one of the leading groups on (genetic) epidemiology of breast cancer in Germany. She has carried out multi-center, collaborative clinical/epidemiologic studies for risk and prognosis of breast and colorectal cancer and investigated gene-environmental interaction, has contributed to research activities of international consortia on breast, ovarian and colorectal cancer, and was responsible for collating/harmonizing epidemiologic data for over tl_files/tigacenter/images/eu-digipath/dkfz.jpg50 studies and statistical data analysis in an FP7 project COGS. She is partner in the NCT program area “Cancer Prevention, Control and Outcomes” and (co)author of over 400 scientific publications.

Prof. Dr. Jeroen van der Laak

tl_files/tigacenter/images/eu-digipath/vd_laak.jpgProf. Dr. Jeroen van der Laak is senior researcher and group leader of digital pathology research at the department of pathology of the Radboud University Medical Center in Nijmegen, The Netherlands. The work of his group pioneers the development of computer aided diagnosis software and methods for whole-slide-images. He is associate researcher with the diagnostic image analysis group (DIAG) of the radiology department at his institution, has over 20 years of research experience, is PI for diverse projects on digital pathology and is member of the steering committee on digital image exchangetl_files/tigacenter/images/eu-digipath/umc.jpg of the Dutch federation of pathologists (NVVP). He (co)authored more than 80 peer-reviewed publications.

Prof. Dr. Jean-Philippe Girard

tl_files/tigacenter/images/eu-digipath/girard.jpgProf. Dr. Jean-Philippe Girard is director of Institute of Pharmacology and Structural Biology (IPBS) in France, and head of the Department “Vascular Biology: Endothelial cells, Inflammation and Cancer”. The academic team is a multidisciplinary basic research team regrouping researchers, engineers, technicians and PhD students with complementary expertise in molecular and cellular biology, biochemistry, functional genomics, immunology, tl_files/tigacenter/images/eu-digipath/ipbs.jpgphysiology and in vivo imaging. The team brings its > 20 years expertise on HEV blood vessels and its leadership on the topic at the international level.

Dr. Marjanka K. Schmidt

tl_files/tigacenter/images/eu-digipath/schmidt.jpgDr. Marjanka K. Schmidt leads a group in the Division of Molecular Pathology, the Netherlands Cancer Institute. She has carried a number of collaborative national and international epidemiological studies with large cohort of breast cancer patients and focuses on the effects of genetic variants on risk of breast cancer subtypes, tl_files/tigacenter/images/eu-digipath/nci.jpgprognosis and long-term outcome of breast cancer, combining the areas of epidemiological and molecular research and has (co)authored more than 80 scientific publications.

 

Prof. Dr. Silvia Pastoreková

tl_files/tigacenter/images/eu-digipath/pastorekova.jpgProf. Dr. Silvia Pastoreková is the Head of the Department of Molecular Medicine at IVS, Slovak Academy of Sciences. Her team focuses on understanding cancer progression by studying molecular and cellular mechanisms of tumor cell adaptation to hypoxia and acidosis. She and colleagues have identified carbonic anhydrase IX (CA IX)tl_files/tigacenter/images/eu-digipath/ivb.jpg that is currently accepted as one of the best and clinically useful biomarkers of tumor hypoxia. She participated in two integrated hypoxia-related project consortia of the 6th and 7th EU Framework program and is co-author of over 160 publications.


 
hamamatsu, tiga center, tiga centre, tiga, epithelial, tissue, tissue analysis, tissue modelling, tissue imaging, hautsimulation, episim, imaging, analysis, model, modelling, Heidelberg, Universität Heidelberg, Bioquant, epithel, medizinische informatik, pathology, modeller, medical informatics